Acumen Pharmaceuticals (ABOS) Depreciation & Amortization (CF) (2021 - 2026)
Acumen Pharmaceuticals recorded quarterly Depreciation & Amortization (CF) of $12000.0 in Q1 2026, little changed quarter-over-quarter from $12000.0 in Q4 2025, and down 20.0% year-over-year from $15000.0 in Q1 2025.
Acumen Pharmaceuticals' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $12000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 20.0% year-over-year to $12000.0; the TTM figure through Mar 2026 stood at $55000.0 (down 11.29% YoY), while the FY2025 annual figure was $58000.0, down 7.94% from the prior year.
- Depreciation & Amortization (CF) came in at $12000.0 for Q1 2026 at Acumen Pharmaceuticals, roughly flat from $12000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $19000.0 in Q4 2023 to a low of $4000.0 in Q1 2022.
- A 5-year average of $13294.1 and a median of $14000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 300.0% in 2022 and slipped 26.32% in 2024, its largest moves.
- Acumen Pharmaceuticals' Depreciation & Amortization (CF) stood at $12000.0 in 2022, then surged by 58.33% to $19000.0 in 2023, then dropped by 26.32% to $14000.0 in 2024, then retreated by 14.29% to $12000.0 in 2025, then changed by 0.0% to $12000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $12000.0, $12000.0, and $15000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |